Observation of the medium-long term efficacy of infusion chemotherapy in middle-terminal stage esophageal carcinomas
- VernacularTitle:中晚期食管癌动脉灌注化疗中远期疗效观察
- Author:
Taimin SONG
;
Xinwei HAN
;
Gang WU
- Publication Type:Journal Article
- Keywords:
Esophageal carcinoma;
Chemotherapy;
Radiology, interventional
- From:
Journal of Interventional Radiology
1994;0(02):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the infusion chemotherapeutic efficacy and clinical application value for patients with middle-terminal stage esophageal carcinomas.Methods Eighty patients with esophageal squamous carcinoma confirmed with barium meal examination and histopathology were undergone angiography and infusion chemotherapy through catheter in the target artery of the esophageal tumor.Results Complete reliefs were acquired in 26 of 80 patients after the infusion, partial relief in 42, no-change in 11 and progress in 1; the overall effective rate was 85%(68/80). The survival rates was 87.5%(70/80), 38.8%(31/80), 21.3%(17/80), 15%(12/80) at 1, 2, 3 and 5 year intervals respectively. The patients of more than 3 years survival were complete symtomlessness after infusion. The survival rate could be improved significantly with infusion as long as necessary.Conclusions The short-term efficacy with infusion is remarkable and should be the preferable choice, but the medium-long term survival rate is still low. Accomplishment with other therapies is further to be recommeded.
